[go: up one dir, main page]

AU4530997A - Glycosylation-mediated inhibition of factor X - Google Patents

Glycosylation-mediated inhibition of factor X

Info

Publication number
AU4530997A
AU4530997A AU45309/97A AU4530997A AU4530997A AU 4530997 A AU4530997 A AU 4530997A AU 45309/97 A AU45309/97 A AU 45309/97A AU 4530997 A AU4530997 A AU 4530997A AU 4530997 A AU4530997 A AU 4530997A
Authority
AU
Australia
Prior art keywords
glycosylation
factor
mediated inhibition
mediated
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU45309/97A
Other versions
AU717123B2 (en
Inventor
Uma Sinha
David L. Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU39177/93A external-priority patent/AU681074B2/en
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Priority to AU45309/97A priority Critical patent/AU717123B2/en
Publication of AU4530997A publication Critical patent/AU4530997A/en
Application granted granted Critical
Publication of AU717123B2 publication Critical patent/AU717123B2/en
Assigned to MILLENNIUM PHARMACEUTICALS, INC. reassignment MILLENNIUM PHARMACEUTICALS, INC. Alteration of Name(s) in Register under S187 Assignors: COR THERAPEUTICS, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU45309/97A 1992-03-20 1997-11-19 Glycosylation-mediated inhibition of factor X Ceased AU717123B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU45309/97A AU717123B2 (en) 1992-03-20 1997-11-19 Glycosylation-mediated inhibition of factor X

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85410992A 1992-03-20 1992-03-20
AU39177/93A AU681074B2 (en) 1992-03-20 1993-03-11 Glycosylation-mediated inhibition of factor X
US854109 1997-05-09
AU45309/97A AU717123B2 (en) 1992-03-20 1997-11-19 Glycosylation-mediated inhibition of factor X

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU39177/93A Division AU681074B2 (en) 1992-03-20 1993-03-11 Glycosylation-mediated inhibition of factor X

Publications (2)

Publication Number Publication Date
AU4530997A true AU4530997A (en) 1998-02-12
AU717123B2 AU717123B2 (en) 2000-03-16

Family

ID=25624677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45309/97A Ceased AU717123B2 (en) 1992-03-20 1997-11-19 Glycosylation-mediated inhibition of factor X

Country Status (1)

Country Link
AU (1) AU717123B2 (en)

Also Published As

Publication number Publication date
AU717123B2 (en) 2000-03-16

Similar Documents

Publication Publication Date Title
PL313619A1 (en) Derivatives of piperydine
PL310443A1 (en) Derivatives of pyrolo-pyridine
AU4013193A (en) Method of maintaining relationships between elements
AU2588292A (en) Aminodiesters of rapamycin
AU4623193A (en) Corrosion inhibition composition
PL306127A1 (en) Derivatives of epi-epibathydine
AU5218593A (en) Method of milling
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3042892A (en) Rockbolt
AU8551191A (en) Inhibition of scale
AU3803593A (en) Compounds
AU4772493A (en) Sulfo-derivatives of adenosine
AU3733793A (en) Iodine derivatives of tetrabenazyne
AU5323694A (en) 17beta -carboxanilides of 4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors
AU5188093A (en) Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones
AU5184393A (en) Substituted derivatives of diaminophthalimide
AU3922493A (en) Inhibition of P70 S6 kinase
AU6723294A (en) Use of simmondsine
AU3461693A (en) Saddle-cloth
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU4720593A (en) Coating of components
AU3724593A (en) Polyfluoroalkylation of aromatic compounds
AU3359493A (en) Determination of haptens
AU5371694A (en) Use of the tarchonanthus camphoratus

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: MILLENNIUM PHARMACEUTICALS, INC.

Free format text: FORMER OWNER WAS: COR THERAPEUTICS, INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired